Remedium Lifecare Ltd

For the twelfth consecutive session, Remedium Lifecare Ltd has closed lower, culminating in a fresh 52-week low of Rs 0.26 on 16 Jun 2026. This extended decline has wiped out over 31.5% of its value in less than three weeks, underscoring persistent selling pressure amid a broader market that remains buoyant.

For the eleventh consecutive session, Remedium Lifecare Ltd has closed lower, plunging to a fresh 52-week low of Rs 0.27 on 15 Jun 2026, marking a steep decline of 28.95% over this period amid persistent selling pressure.

Remedium Lifecare Ltd’s stock price declined to a fresh 52-week low of Rs.0.28 on 12 June 2026, marking a significant milestone in its ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent financial and market pressures.

For the ninth consecutive session, Remedium Lifecare Ltd has closed lower, culminating in a fresh 52-week low of Rs 0.29 on 11 Jun 2026. This marks a steep 23.68% decline over this losing streak and a staggering 75.63% drop over the past year, far outpacing the Sensex’s 10.70% fall in the same period.

Remedium Lifecare Ltd’s share price declined to a fresh 52-week low of Rs.0.3 on 10 June 2026, marking a significant downturn amid ongoing financial difficulties and sustained underperformance relative to market benchmarks.

For the seventh consecutive session, Remedium Lifecare Ltd has closed lower, culminating in a fresh 52-week low of Rs 0.31 on 9 June 2026. This persistent decline has dragged the stock down by 18.42% over this period, underscoring a sustained sell-off amid weak fundamentals and challenging market conditions.

Remedium Lifecare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 16 Nov 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Remedium Lifecare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 16 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 13 May 2026, providing investors with the latest insights into its performance and prospects.

Remedium Lifecare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 16 Nov 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Remedium Lifecare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 16 Nov 2024. However, the analysis and financial metrics presented here reflect the company’s current position as of 12 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook.

A sharp decline has pushed Remedium Lifecare Ltd to a fresh 52-week low of Rs 0.32 on 30 Mar 2026, marking a significant 83.5% drop from its 52-week high of Rs 1.94. This steep fall comes amid a broader market downturn, but the stock’s underperformance far exceeds sector and benchmark indices, raising questions about the underlying causes and prospects for recovery.

Remedium Lifecare Ltd’s share price declined to a fresh 52-week low of ₹0.33 on 27 March 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent financial and operational pressures.

For the ninth consecutive session, Remedium Lifecare Ltd has closed lower, culminating in a fresh 52-week low of Rs 0.34 on 25 Mar 2026. This extended decline has wiped out over 27.6% of its value in just over a week, underscoring persistent selling pressure amid a broader market that is showing signs of resilience.

Remedium Lifecare Ltd’s share price declined to a fresh 52-week low of ₹0.35 on 24 March 2026, marking a significant downturn for the micro-cap company within the Trading & Distributors sector. The stock has experienced sustained pressure, reflecting a series of financial setbacks and market headwinds.

For the seventh consecutive session, Remedium Lifecare Ltd has closed lower, culminating in a fresh 52-week low of Rs 0.36 on 23 Mar 2026. This marks a steep 23.4% decline over the past week, underscoring persistent selling pressure amid a challenging market backdrop.

For the seventh consecutive session, Remedium Lifecare Ltd has closed lower, culminating in a fresh 52-week low of Rs 0.36 on 23 Mar 2026. This marks a steep 23.4% decline over the past week, underscoring persistent selling pressure amid a broader market downturn.

Remedium Lifecare Ltd’s stock price declined sharply to a new 52-week and all-time low of Rs.0.37 on 20 Mar 2026, marking a significant downturn for the micro-cap company in the Trading & Distributors sector. The stock has underperformed its sector and broader market indices amid persistent negative financial results and subdued operational metrics.

Remedium Lifecare Ltd, a micro-cap player in the Trading & Distributors sector, has touched a fresh 52-week and all-time low of Rs.0.38 today, marking a significant decline in its stock price amid continued underperformance and challenging financial metrics.

Remedium Lifecare Ltd has reached a new 52-week and all-time low of Rs.0.39, marking a significant decline in its stock price amid ongoing negative financial performance and sector underperformance.